Metformin Might Inhibit Virus through Increasing Insulin Sensitivity
Abstract
To the Editor: Metformin is believed to be the most widely used medication for diabetes as well as the first‐line medication for the treatment of type 2 diabetes, especially in patients who are overweight. Metformin is described as a magic medicine currently due to its broad range of potential benefits for polycystic ovary syndrome, cardiovascular disease, and various cancers and even prolonged lifespan. Recently, limited in vitro and in vivo research suggests that metformin may have inhibitory effect on virus, especially hepatitis C virus (HCV). Besides, it would be amazing if metformin possess antivirus function in hepatitis B virus (HBV), human immunodeficiency virus (HIV), etc., to benefits virus‐infected patients from other aspects of mechanism.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.